FDA Inspection 1142828 — Ignace B. P. Vergote, MD, PhD
The FDA completed an inspection of Ignace B. P. Vergote, MD, PhD on May 28, 2021 in Leuven. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 28, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Leuven (Belgium)
Additional Details
Clinical Investigator (CI)